epilactose has been researched along with Obesity in 1 studies
*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsui, H; Mori, H; Murakami, Y; Ojima-Kato, T; Saburi, W; Suzuki, T; Tanabe, S | 1 |
1 other study(ies) available for epilactose and Obesity
| Article | Year |
|---|---|
Supplemental epilactose prevents metabolic disorders through uncoupling protein-1 induction in the skeletal muscle of mice fed high-fat diets.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Cell Line; Diet, High-Fat; Disaccharides; Energy Metabolism; Fermentation; Gastrointestinal Microbiome; Ion Channels; Macrophage Activation; Male; Mice, Inbred C57BL; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Prebiotics; Propionates; Random Allocation; Uncoupling Protein 1; Up-Regulation | 2015 |